The Latest Advancement in Vision Correction Surgery
At our eye care practice, we take pride in offering you a variety of advanced vision correction options so we can find the best vision solution for you. We are excited to announce that the EVO ICL Lens, which earned FDA approval in the United States in March 2022, is now available for our patients in INSERT TARGET LOCATION.
EVO ICL is an Implantable Collamer® Lens that is designed to give you sharp, clear vision.1,2 Like LASIK or PRK, EVO ICL is a refractive surgery that can correct nearsightedness (myopia) and astigmatism. What sets ICL apart is that it can correct a high range of myopia without removing any corneal tissue or contributing to dry eye syndrome.
The EVO ICL Lens is made of Collamer, a biocompatible material that is flexible and works in harmony with your eye. The lens is implanted in a 20 to 30 minute procedure and patients enjoy a quick recovery time.
Learn More About the ICL Procedure
If you are seeking freedom from glasses or contact lenses, the EVO ICL may be right for you. Potential candidates are:
Interested in learning more about vision correction with the EVO ICL Lens? A consultation appointment is the best way to decide if it is right for you and to get answers to any questions you have about achieving your best possible vision without the hassles of glasses or contact lenses. Contact us
References: (1) Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125. (2) Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53. (3) Parkhurst G. A prospective comparison of phakic Collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clinical Ophthalmology. 2016. (4) Naves J, et al.. Diadenosine nucleotide measurements as dry-eye score in patients after LASIK and ICL surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.